fbpx

    AACR-Johnson & & Johnson Lung Cancer Development Science Grants 2019 (Approximately $1,000,000)

    0
    AACR-Johnson & & Johnson Lung Cancer Development Science Grants 2019 (Approximately $1,000,000)

    Due Date: July 19, 2019

    Applications are open for the AACR-Johnson & Johnson Lung Cancer Development Science Grants 2019 The grants represent a collaboration to deal with the requirement for promoting and supporting collective cancer research study in locations that consist of digital therapies and smoking cigarettes cessation biomarkers/behavioral phenotyping, to boost the understanding of how lung cancer can be effectively obstructed.

    Focused on locations of interest might consist of: medical trials that would determine distinct high-risk clients for lung cancer and show continual effectiveness through the measurement of both give up rates, along with disease-related biomarkers; medical trials that would determine digital therapies concentrated on smoking cigarettes avoidance for novice cigarette smokers or for previous cigarette smokers; these therapies might think about the effect of social engagement, video gaming, and other content pertinent for populations at a danger of beginning or resuming their smoking cigarettes routine. The addition of a tactical strategy for medical verification of the digital healing research study is advised.

    Grant

    • The Grant will supply $1,000,000 in moneying for direct and indirect costs connected to each research study job over a three-year timeframe.

    Eligibility

    • There are no citizenship or geographical requirements; nevertheless, by sending an application for this grant, a candidate using from an organization situated in a nation in which they are not a resident or an irreversible local guarantees that the visa status will supply adequate time to finish the job and grant term at the organization from which they used.
    • A minimum of 2, however no greater than 3, co-applicants from unique organizations are needed. The group will be directed by the Lead Principal Private Investigator (Lead PI) and consist of as much as 2 extra co-Principal Detectives (co-PIs). The Lead PI is accountable for the application, dispensation of funds to the numerous research study tasks, the conduct of the tasks, and development reporting.
    • Principal Private Investigators (PIs) should have a postgraduate degree (consisting of PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD, or comparable postgraduate degree) in the biomedical sciences or in a field relevant to health science research study and not presently be a prospect for an additional doctoral or expert degree.
    • In addition to the co-PIs, the Task Group ought to likewise consist of a minimum of one young private investigator (e.g., postdoctoral or medical research study fellow; junior professor). While not a co-PI, this young private investigator must play a crucial function in the job.
    • Applications will be accepted from independent private investigators at all levels who are associated with a scholastic, medical, or research study organization throughout the world.
    • AACR subscription is needed. Nonmembers thinking about grant chances should send an acceptable application for AACR subscription, and be members in excellent standing, by the application due date.

    Research Study Task Criteria

    • Propositions will be accepted for originalities and ingenious techniques that have direct application and importance to lung cancer avoidance and interception. Proposed research study must be translational in nature and consist of a scientific element with an endpoint pertinent to enhancing the detection or treatment of lung cancer.
    • Propositions ought to concentrate on the locations of recognition of populations at high threat for lung cancer, consisting of digital therapies, smoking cigarettes cessation biomarkers, and/or behavioral phenotyping. Focused on locations of interest might consist of: medical trials that would determine distinct high-risk clients for lung cancer and show continual effectiveness through the measurement of both give up rates, along with disease-related biomarkers; medical trials that would determine digital therapies concentrated on smoking cigarettes avoidance for novice cigarette smokers or for previous cigarette smokers- these therapies might think about the effect of social engagement, video gaming, and other content pertinent for population at a danger of beginning or resuming their smoking cigarettes routine. The addition of a tactical strategy for medical verification of the digital healing research study is advised.

    Application

    Click on this link to use

    For more details, see AACR-Johnson & Johnson Grants